Servet HACIVELİOĞLU, Hasan KAFALI, Nermin KÖŞÜŞ, Aydın KÖŞÜŞ, Deniz HIZLI, Zeynep KAMALAK, Nilgün TURHAN, Banu AKÇAL, Hatice KÖŞGER

Türk adölesan kızlarda vücut kitle indeksinin akne, hirsutism ve menstrüel düzensizlik semptomları üzerine etkisi

Amaç: Bu çalışmanın amacı sağlıklı adölesan popülasyonda vücut kitleindeksinin (VKİ) polikistik over sendromların (PKOS)dan olan akne, hirsutismve menstrüel düzensizlik semptomları üzerindeki etkilerini incelemektir.Materyal ve metod: On beş farklı ortaöğretim okulunda okuyan gönüllü kızöğrencilere anket soruları dağıtıldı. Öğrencilerin VKİ, doğum ağırlığı, menarşyaşı, menstruel düzeni ve akne ve hirsutism şikayetlerinin varlığı kaydedildi.Olgular VKİe göre Grup 1; ≤18.4 kg/m2, Grup 2; 18.5-24.9 kg/m2, Grup 3; 25-29.9 kg/m2 ve Grup 4; >30 kg/m2 şeklinde gruplandırıldı. VKİ ile akne,hirsutism ve menstruel düzensizlik semptomları arasındaki ilişki incelendi.Bulgular: Toplam 1309 öğrenci anketi tam doldurdu ve çalışmaya dahil edildi.Bu öğrencilerden 314ü Grup 1de, 899u Grup 2de, 81i Grup 3de, 15I Grup4de idi. Öğrencilerin ortanca yaşı 16 yıl (13-20 yıl) ve ortanca menarş yaşı 13 ıl (11-16 yıl) idi. Toplam 106 (% 8,1) öğrenci menstrual düzensizlik tarifledi.Düşük kilolu kızlar normal kilolu kızlara gore anlamlı olarak daha az akne(p=0,001) ve hirsutism (p

The effect of body mass ındex on acne, hirsutism and menstrual ırregularity symptoms in turkish adolescent girls

Purpose: The aim of the present study was to determine whether body mass index (BMI) influences polycystic ovary syndrome (PCOS) related symptoms such as acne, hirsutism and menstrual irregularity in a large healthy adolescent population. Methods: Self-administered questionnaires were distributed to all volunteer female students at 15 different secondary schools. The subjects BMI,birthweight, age at menarche, pattern of menstrual cycle and presence of acne or hirsutism complaints were recorded. Subjects with BMI of ≤18.4kg/m2, 18.5-24.9 kg/m2, 25-29.9 kg/m2 and >30 kg/m2 were defined as group 1, group 2, group 3 and group 4, respectively. The relation between BMI and the symptoms of acne, hirsutism and menstrual irregularity was analyzed. Results: A total of 1309 students filled the questionnaires properly and included in the study. Of these students, 314 were in group 1, 899 in group 2, 81 in group 3 and 15 in group 4. The median ages of participants were 16 years (range 13-20 years) and median age at menarche was 13 years (range of 11-16 years). A total of 106 (8.1%) participants reported various menstrual irregularity. Underweighed girls had significantly less acne (p=0.001) and hirsutism problems (p

PDF

___

1- Belosi C, Selvaggi L, Apa R, Guido M, Romualdi D, Fulghesu AM, ET AL. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? Hum reprod 2006;21:310815.
2-Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007;370:685-97.
3-Setji TL, Brown AJ. Comprehensive clinical management of polycystic ovary syndrome. Minerva Medica 2007;98:175-89.
4-Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yıldız BO. The prevalence andfeatures of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-49.
5-Pasquali R. Obesity and androgens: fact and perspectives. Fertil Steril 2006;85:1319-40.
6-Cattrall FR, Healy DL. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:803-12.
7-Broekmans FJ, Knauff EAH, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BCJM. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006;113:1210-7.
8-Sayin NC, Gucer F, Balkanli-Kaplan P, Yuce MA, Ciftci S, Kucuk M, et al. Elevated serum TNF-alfa levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome. J Reprod Med 2003;48:165-70.
9-Seow KM, Juan CC, Wu LY, Hsu YP, Yang WM, Tsai YL, et al. Serum and adipocyte resistin in polycystic ovary syndrome with insülin resistance. Hum Reprod 2004;19:48-53.
10-Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Alvarez-Blasco F, Sanchon R, Luque-Ramirez M, et al. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod 2006;21:2257-65.
11-Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med 2006;119:351-6.
12-Sepilian VP, Crochet JR, Nagamani M. Serum soluble leptin receptor levels and free leptin index in women with plycystic ovary syndrome: relationship to insülin resistance and androgens. Fertil Steril 2006;85:1441-7.
13-Rosenbaum D, Haber RS, Dunaif A. Insulin resistance in polycystic ovary syndrome: dereased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol 1993; 264:197-202.
14-Chang RJ, Nakamura RM, Judd HL, Kaplan SA. J Clin Endocrinol Metab. 1983;57:356-9.
15-Dunaif A, Segal KR, Futterweit W, Dobrjanksy A. Profound Peripheral Insulin Resistance Independent of Obesity in Polyctystic Ovary Syndrome. Diabetes 1989;38: 1165-74.
16-Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS. Insulin, somatotropic and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome:common and distinct features, J Clin Endocrinol Metab 1996;81:2854-64.
17-Anttila L, Ding YQ, Ruutiainen K, Erkkola R, Irjala K, Huhtaniemi I. Clinical features and circulating gonadotropin insulin and androgen interactions in women with polycystic ovarian disease. Fertil Steril 1991;55:1057-61.
18-Insler V, Shoham Z, Barash A, Koistinen R, Seppölö M, Hen M, et al. Polycystic ovaries in non-obese and obese patients; possibl pathophysiological mechanism based on new interpretation of facts and findings. Hum Reprod 1993;8:379-84.
19-Guastella E, Longo RA, Carmina E. Clinical and endocrine characteristics of the main polycystics ovary syndrome phenotyes. Fertility and Sterility 2010;94:2197-201.
20-Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1996;10:2107-11.
21-Centers for Disease Control and Prevention 2005 US Obesity trends, 1985- 2005. Atlanta: Centers for Disease Control and Prevention.
22- Yildiz BO, Knochenhauer ES, Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:162-8.